| 摘要 |
PROBLEM TO BE SOLVED: To provide an osteoporosis-sensitive gene; a method for determining an osteoporosis morbidity risk; and a medicine characterized by being administered into a person having an osteoporosis contraction risk; and to provide an osteoporosis contraction risk diagnosis marker used for the determination method; a probe; a primer; and a reagent kit. SOLUTION: There is provided a genetic polymorphism present in a human SMAD6 gene, TGFβR1 gene, Syntaxin18 gene, WDSOF1 gene, ADAMTS1 gene, FAM5C gene neighborhood, GPR98 gene neighborhood, GPR98 gene, SLC25A32 gene, CTHRC1 gene neighborhood, CTHRC1 gene, or FDZ6 gene, as an osteoporosis-sensitive gene. There is also provided an osteoporosis medicine kit including a means for specifying a person having an osteoporosis contraction risk. COPYRIGHT: (C)2010,JPO&INPIT |
